Protagonist Therapeutics PTGX
NASDAQ PTGX
$140.06 +0.87 (+0.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Price to FCF (2017 - 2026)

Updated

Protagonist Therapeutics' Price to FCF was 60.71 in Q2 2026, down 34.4% from 92.53 a year earlier.

Analysis

Protagonist Therapeutics (PTGX) Price to FCF (2017 - 2026) Analysis & Trends

For FY2025, Price to FCF at Protagonist Therapeutics came in at 97.46, up 656.2% from FY2024.

  • In earlier years, Price to FCF was 12.89 in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Price to FCF since Q1 2025.
  • Compared with a year earlier, Price to FCF was higher in three of the last four quarters, with growth averaging 507.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Protagonist Therapeutics 9.06 Bn 9.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.71
Dec 31, 2025 97.46
Sep 30, 2025 65.11
Jun 30, 2025 92.53
Mar 31, 2025 8.93
Dec 31, 2024 12.89
Sep 30, 2024 11.68
Jun 30, 2024 8.82
Dec 31, 2017 136.82
Sep 30, 2017 38.99
API Access

Protagonist Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PTGX&period=max&api_key=YOUR_API_KEY